FCCC LOGO Faculty Publications
Carroll PR , Parsons JK , Andriole G , Bahnson RR , Castle EP , Catalona WJ , Dahl DM , Davis JW , Epstein JI , Etzioni RB , Farrington T , Hemstreet GP 3rd , Kawachi MH , Kim S , Lange PH , Loughlin KR , Lowrance W , Maroni P , Mohler J , Morgan TM , Moses KA , Nadler RB , Poch M , Scales C , Shaneyfelt TM , Smaldone MC , Sonn G , Sprenkle P , Vickers AJ , Wake R , Shead DA , Freedman-Cass DA
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016
J Natl Compr Canc Netw. 2016 May;14(5) :509-19
PMID: 27160230   
Back to previous list
Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.
Notes
Carroll, Peter R Parsons, J Kellogg Andriole, Gerald Bahnson, Robert R Castle, Erik P Catalona, William J Dahl, Douglas M Davis, John W Epstein, Jonathan I Etzioni, Ruth B Farrington, Thomas Hemstreet, George P 3rd Kawachi, Mark H Kim, Simon Lange, Paul H Loughlin, Kevin R Lowrance, William Maroni, Paul Mohler, James Morgan, Todd M Moses, Kelvin A Nadler, Robert B Poch, Michael Scales, Chuck Shaneyfelt, Terrence M Smaldone, Marc C Sonn, Geoffrey Sprenkle, Preston Vickers, Andrew J Wake, Robert Shead, Dorothy A Freedman-Cass, Deborah A United States J Natl Compr Canc Netw. 2016 May;14(5):509-19.